(Q41738674)

8 October 2017

1 reference

title

Free radicals and the pathobiology of brain dopamine systems (English)

1 reference

8 October 2017

Cadet JL

1

1 reference

PubMed ID

9542724

8 October 2017

Brannock C

series ordinal

2

1 reference

8 October 2017

1 February 1998

1 reference

Neurochemistry International

8 October 2017

1 reference

8 October 2017

32

1 reference

8 October 2017

117-131

1 reference

8 October 2017

2

1 reference

Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E.

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Cytotoxicity of microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Differing neurotoxic potencies of methamphetamine, mazindol, and cocaine in mesencephalic cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

A unifying theory of movement and madness: involvement of free radicals in disorders of the isodendritic core of the brainstem

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynaptic nigrostriatal markers in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Hydroperoxide metabolism in mammalian organs

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Methamphetamine-induced neuronal damage: a possible role for free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Monoamines in the human neostriatum: Topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Ascorbate is an outstanding antioxidant in human blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Superoxide Radical: An Endogenous Toxicant

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Biological effects of the superoxide radical

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Characterization of ameboid microglia isolated from developing mammalian brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Colony-stimulating factors as promoters of ameboid microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Idiopathic parkinsonism with lewy-type inclusions in cerebral cortex. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Role of nerve growth factor in oxidant-antioxidant balance and neuronal injury. I. Stimulation of hydrogen peroxide resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Glutathione peroxidase activity in Parkinson's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Nitric oxide: a pathogenetic factor in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Survival of developing dopaminergic neurons in reaggregate tissue culture following treatment with methamphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Relationship between mitochondrial superoxide and hydrogen peroxide production and longevity of mammalian species

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

NMDA-dependent superoxide production and neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Nitric oxide, superoxide and peroxynitrite: putative mediators of NMDA-induced cell death in cerebellar granule cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

1 reference

7 January 2021

Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

N-methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Superoxide dismutase, glutathione peroxidase and catalase in developing rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Rate of cell death in parkinsonism indicates active neuropathological process

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Long-lasting decrease in dopamine uptake sites following repeated administration of methamphetamine in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Nitric oxide as a secretory product of mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Regional effects of 6-hydroxydopamine (6-OHDA) on free radical scavengers in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Tetrahydroisoquinoline alkaloids: in vivo metabolites of L-dopa in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Methamphetamine (METH) causes reactive gliosis in vitro: attenuation by the ADP-ribosylation (ADPR) inhibitor, benzamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Long-term effects of continuous exposure to amphetamine on brain dopamine concentration and synaptosomal uptake in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Intranigral injected iron progressively reduces striatal dopamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900031-4

7 January 2021

10.1016/S0197-0186(97)00031-4

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9542724